Inflammatory bowel disease and Parkinson's disease are chronic progressive disorders that
mainly affect different organs: the gut and brain, respectively. Accumulating evidence has …

There is a considerable body of evidence indicating that chronic adverse experience,
especially chronic psychosocial stress/trauma, represents a major risk factor for the …

Background The latest estimate of the prevalence of inflammatory bowel disease (IBD) in the
United States was based on 2009 data, which indicates a need for an up-to-date re …

Despite immunosuppression is critical for reducing immune overactivation, existing
immunosuppressive agents are largely restricted by low inhibition efficiencies and …

The association of diabetes with inflammatory bowel disease (IBD) remains unclear. The risk
of diabetes in patients with IBD compared with non-IBD controls was investigated. Using the …

Background: Continuation of biologics for inflammatory disorders during pregnancy is still a
difficult decision. Many women with inflammatory bowel diseases (IBDs) stop anti–tumor …

Despite considerable epidemiological evidence indicating comorbidity between metabolic
disorders, such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease, and …

Individuals with Inflammatory Bowel Disease (IBD) are characterized by an increased
vulnerability to complications stemming from infectious diseases. While these patients do not …

In 2018, 0.40% and 0.64% of 25.1 million Medicare fee-for-service beneficiaries aged≥ 67
years had received a diagnosis of Crohn's disease or ulcerative colitis. From 2001 to 2018 …

Background: Adults have a higher prevalence of multimorbidity—or having multiple chronic
health conditions—than having a single condition in isolation. Researchers, health care …